Physician profile
Johnny Thomas
NPI 1619906047
$2,691.21
in general payments reported to CMS, 2019-2025
17 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $128 · 2024: $1,315 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,575 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,575.27 |
| Education | $115.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $778.86 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $391.55 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $243.18 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $241.75 | 2024-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $205.38 | 2024-2025 | Rexulti |
| Amgen INC. | $174.37 | 2023-2025 | Repatha, Otezla, Repatha |
| Actelion Pharmaceuticals US, INC. | $167.07 | 2024-2025 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $139.72 | 2024-2025 | |
| Lilly USA, LLC | $118.57 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $59.14 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.68 | 2024-2025 | Jardiance |
| Astellas Pharma US INC | $26.77 | 2025 | Veozah |
| Abbvie INC. | $23.34 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.89 | 2024 | Gvoke Hypopen |
| Lundbeck LLC | $22.44 | 2025 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $20.68 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Smith+Nephew, INC. | $16.82 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.